Search Medicilon

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Medicilon and Protheragen Forge Strategic Partnership to Build a Collaborative “Project + Platform” Model

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

AOC Development: Conjugation Site Selection, DAR Control & In Vitro Testing | Full Webinar

Meet Medicilon at BioTrinity 2026

BioTrinity 2026

Contact Medicilon

Name(Required)
Address(Required)